Bunkerhill MAC vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS

AI Verdict

Tool A focuses on analyzing CT scans for mitral annular calcification to identify cardiovascular risk, leveraging AI for image interpretation. In contrast, Tool B is an insertable cardiac monitor that uses AI for continuous heart rhythm monitoring to diagnose arrhythmias. While both fall under cardiology AI and clinical decision support, they address distinct clinical problems with different technological approaches.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your primary goal is to proactively identify patients at increased cardiovascular risk by leveraging existing routine, non-gated chest CT scans. This tool is ideal for health systems looking to automate the detection and quantification of mitral annular calcification (MAC) to facilitate early intervention and streamline care coordination through an integrated AI platform.

View Bunkerhill MAC →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II if you require long-term, continuous heart rhythm monitoring to diagnose infrequent or symptomatic arrhythmias that are difficult to capture with conventional methods. This insertable cardiac monitor is best suited for patients needing extended surveillance, offering AI-powered accuracy and remote management capabilities for comprehensive arrhythmia detection.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill MAC LINQ II Insertable Cardiac Monitor
Pricing Contact for pricing Enterprise
Deployment Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform. Hybrid
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill MAC

Bunkerhill MAC emphasizes seamless integration with existing EHRs and clinical systems, analyzing routine CT scans without disrupting current workflows. This focus on passive, integrated clinician use within familiar environments makes it highly usable for healthcare providers. In contrast, LINQ II involves an implanted device and patient interaction with a mobile app, introducing a different layer of usability considerations for patients rather than purely clinician workflow.

Clinical Value

LINQ II Insertable Cardiac Monitor

Medtronic LINQ II offers long-term, continuous heart rhythm monitoring for up to 4.5 years, with enhanced AI accuracy for diagnosing arrhythmias and a pediatric indication. This provides sustained diagnostic utility across a broader patient population. While Bunkerhill MAC offers significant value in early cardiovascular risk identification from existing scans, LINQ II's continuous, long-term diagnostic capability for a range of arrhythmias presents a wider and deeper clinical impact.

Pricing & Value

Tie

Both tools operate on an enterprise pricing model that is not publicly disclosed, requiring direct contact for quotes. Without specific pricing details or transparent value propositions, it is impossible to conduct a meaningful comparison or determine which offers superior value. Therefore, this dimension is a tie.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic LINQ II demonstrates superior enterprise readiness with explicit HIPAA compliance, FDA clearance, a hybrid deployment model, and a proven track record with over a million patients worldwide. As a global medical device leader, Medtronic offers established infrastructure and trust. Bunkerhill MAC, while FDA-cleared, is less explicit about its full compliance details and has a less documented enterprise footprint.

Innovation

Bunkerhill MAC

Bunkerhill MAC stands out for its use of 'Generative AI for clinical reasoning and action' to detect and quantify mitral annular calcification on routine, non-gated CT scans. This application of generative AI to extract novel, clinically significant insights from existing imaging data represents a more cutting-edge and transformative approach. While LINQ II features advanced AI for enhanced accuracy and innovative PVC detection, it primarily refines an existing device category.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic LINQ II provides extensive support and documentation, including detailed clinician manuals, patient education brochures, FAQs, and dedicated technical and patient support phone lines. In contrast, Bunkerhill Health's publicly available information primarily focuses on compliance and security reports, lacking readily accessible user-facing product support or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill MAC LINQ II Insertable Cardiac Monitor
Name Bunkerhill MAC LINQ II Insertable Cardiac Monitor
Company Bunkerhill Health Medtronic
Description Bunkerhill MAC is an FDA-cleared AI algorithm by Bunkerhill Health that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination within the Carebricks platform. The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
Key Features AI-powered detection and quantification of Mitral Annular Calcification (MAC); Analyzes routine, non-gated chest CT scans; Identifies patients at increased cardiovascular risk; Integrates with the Carebricks generative AI platform for clinical reasoning and action; Supports automated workflows for follow-up and care coordination; Developed and validated through a multi-institutional research consortium; Seamless integration with existing EHRs and clinical systems AccuRhythmu2122 AI algorithms for enhanced accuracy; Remote programming capability; Up to 4.5 years of continuous monitoring; MRI compatibility (1.5 and 3.0T); MyCareLink Heartu2122 mobile app for data transmission; MyCareLink Relayu2122 home communicator option; Innovative PVC detection algorithm; Pediatric indication (ages 2+)

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC is an FDA-cleared AI algorithm designed to detect and quantify mitral annular calcification (MAC) on routine CT scans, aiding in early cardiovascular risk identification. LINQ II Insertable Cardiac Monitor is an advanced, AI-powered insertable cardiac monitor for long-term, continuous heart rhythm monitoring to diagnose arrhythmias.
Bunkerhill MAC utilizes an FDA-cleared AI algorithm to analyze existing routine, non-gated chest CT scans to identify and quantify MAC. In contrast, LINQ II is an implantable device that continuously records subcutaneous ECG data, using AccuRhythm AI algorithms for enhanced accuracy in detecting heart rhythm events.
Bunkerhill MAC analyzes routine CT scans already performed, so there is no additional patient interaction beyond the initial imaging. LINQ II is an insertable cardiac monitor, requiring a minor surgical procedure for implantation, but it then provides continuous, long-term monitoring without daily patient intervention for up to 4.5 years.
Bunkerhill MAC provides AI-powered detection and quantification of MAC, identifying patients at increased cardiovascular risk and integrating with Carebricks for automated workflows and care coordination. LINQ II offers continuous heart rhythm monitoring data, enhanced by AccuRhythm AI algorithms to improve accuracy and reduce false alerts, assisting in the diagnosis and management of arrhythmias.
Bunkerhill MAC is suited for identifying patients at increased cardiovascular risk by detecting and quantifying MAC on routine CT scans. LINQ II is indicated for adult patients and pediatric patients aged 2 and older who have clinical syndromes or symptoms suggesting cardiac arrhythmias and require long-term, continuous monitoring.
Bunkerhill MAC is a software algorithm analyzing CT scans, so MRI compatibility is not a direct concern for the tool itself. LINQ II is an insertable cardiac monitor that is MRI compatible (1.5 and 3.0T), allowing patients to undergo MRI scans when needed.
AI Tool Finder
AI-powered search. Results may not be comprehensive.